Twist Bioscience stock gains 3.11% as company promotes cost efficient RNA sequencing solutions

Traders Union
All News
Business & Wealth
Companies
Twist Bioscience jumps 3.11% today

Highlights

TWST maintains strong bullish momentum, trading well above major support levels and near its 52-week high at $72.92.
Technical indicators show overbought conditions with a robust upward trend, while intraday and weekly gains reinforce positive sentiment.
Probability models favor continued upside, with expected price consolidation between $70.41 and $71.88 as buyers secure profits.

Twist Bioscience states users can maximize data per run and reduce sequencing volume while increasing usable data. The company cites a 30% improvement in efficiency and the ability to enrich transcripts for greater sensitivity at lower read depths compared to whole transcriptome sequencing methods.

View post on X Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Bullish positioning sustained as price extends beyond key support levels

TWST is trading at $72.33, well above the MA-20 ($59.56), MA-50 ($56.32), and MA-200 ($40.50), confirming ongoing bullish momentum across all timeframes. The Ichimoku Kijun is at $60.48, which now acts as immediate support, while near-term support sits at MA-20 ($59.56) with key support at MA-50 ($56.32), and resistance levels are clustered at the recent high and the top of the weekly range.

Overbought signals emerge as momentum accelerates alongside high volatility

Momentum on D1 is strongly positive, with MACD and ADX both registering buy signals, though the D1 ADX value of 19.09 indicates a trend that could be strengthening. Overbought conditions are flagged by RSI (70.71), Stoch RSI (100.00), and CCI (142.80), suggesting the rally may be stretched in the short term. BBP on D1 shows buyers dominating intraday dynamics, reinforcing the bullish tone, and the Awesome Oscillator supports this trend. In today's session, TWST has risen 3.11%. Over the past week, TWST is trading at $72.33, up from a previous weekly close of $66.87, reflecting an 8.17% gain. The price is at the very top of the weekly range, and weekly volatility stands at a high 15.75%. The tone for the week is a robust upward push with no signs yet of reversal or consolidation.

Upside favored as consolidation expected near annual highs

For the coming week, the expected range is $70.41 to $71.88, keeping the price near its 52-week high of $72.92 and well above the 52-week low of $23.30. Probability modeling based on W1 signals (RSI, ADX, MACD, MA-50, all bullish) indicates a very high probability (more than 80%) of an upward move, while the likelihood of a decline is very low. Baseline scenario: the price consolidates between $70.41 and $71.88 as buyers lock in gains. Bullish scenario: a clear break above $72.92 opens room for further upside, driven by strong trend signals. Bearish scenario: a drop below $70.41 could trigger a pullback toward MA-20 support, but downside risk remains limited given the momentum backdrop.

Earlier, analysts noted that Twist Bioscience was exhibiting a strong bullish trend supported by technical factors and ongoing strategic initiatives. As the current landscape evolves, investors should watch for confirmation of further momentum or signs of consolidation, with attention to any shifts that could present new trading opportunities.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.